Clinical trials
Phase 1 trials in Kazakhstan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2016 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Suspended | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astana Medical University | 2 |
| Industrial Microbiology LLP | 2 |
| Research Institute for Biological Safety Problems | 2 |
| West Kazakhstan Marat Ospanov Medical University | 2 |
| Berlin-Chemie AG Menarini Group | 1 |
| Kazakh National Agrarian University | 1 |
| MIPO Clinic | 1 |
| Nazarbayev University | 1 |
| Petrov, Andrey | 1 |
| Scientific Center for Anti-infectious Drugs, Kazakhstan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aortic Valve Insufficiency | 2 |
| Mitral Valve Insufficiency | 2 |
| Candidiasis, Vulvovaginal | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Coronary Artery Disease | 1 |
| Dysbiosis | 1 |
| Glioblastoma | 1 |
| Gliosarcoma | 1 |
| Heart Diseases | 1 |
| Influenza, Human | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.